Arteris, Inc.·4

Jul 7, 4:22 PM ET

Kunkel Joachim 4

Research Summary

AI-generated summary

Updated

Arteris Director Joachim Kunkel Receives 365-Share Award

What Happened

  • Joachim Kunkel, a director of Arteris, Inc. (AIP), was granted 365 shares of restricted common stock on July 5, 2026. The shares were issued at $0 (award/grant) and are fully vested.
  • The grant value was calculated using the company’s average trading price of $39.28 (May 20–July 2, 2026), valuing the award at approximately $14,337.20. These shares represent retainer fees Kunkel elected to receive in stock instead of cash.

Key Details

  • Transaction date: July 5, 2026; Form 4 filed July 7, 2026 (timely filing).
  • Transaction type/code: Award/Grant (A). Price to insider: $0.00 per share.
  • Shares granted: 365; estimated value based on $39.28 average = $14,337.20.
  • Shares owned after transaction: not disclosed in this filing.
  • Footnotes: F1 — shares are fully vested restricted stock representing retainer fees elected in lieu of cash; F2 — the reporting person elected to defer receipt of shares.
  • Interpretation: This was a compensation award (not a market purchase or sale) and reflects payment of director retainer fees, not an open-market investment.

Context

  • Awards of vested restricted stock are compensation and do not necessarily indicate the insider’s view on the stock’s near-term prospects. Because these shares were fully vested and represent deferred retainer fees, they are routine director compensation rather than a trading signal.